MD3244F1 - Metoda de apreciere a agresivitatii cancerului endometrial - Google Patents

Metoda de apreciere a agresivitatii cancerului endometrial Download PDF

Info

Publication number
MD3244F1
MD3244F1 MDA20060139A MD20060139A MD3244F1 MD 3244 F1 MD3244 F1 MD 3244F1 MD A20060139 A MDA20060139 A MD A20060139A MD 20060139 A MD20060139 A MD 20060139A MD 3244 F1 MD3244 F1 MD 3244F1
Authority
MD
Moldova
Prior art keywords
endometrial cancer
determining
units
level
determined
Prior art date
Application number
MDA20060139A
Other languages
English (en)
Other versions
MD3244G2 (ro
Inventor
Dumitru Sofroni
Lilian GUTU
Katja Tenner
Anatolie CERNII
Corina Cardaniuc
Mihail Todiras
Michael Bader
Original Assignee
Institutia Medico-Sanitara Publica Institutul Oncologic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutia Medico-Sanitara Publica Institutul Oncologic filed Critical Institutia Medico-Sanitara Publica Institutul Oncologic
Priority to MDA20060139A priority Critical patent/MD3244G2/ro
Publication of MD3244F1 publication Critical patent/MD3244F1/ro
Publication of MD3244G2 publication Critical patent/MD3244G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru aprecierea precoce neinvaziva a agresivitatii cancerului endometrial. Esenta inventiei consta in aceea ca se determina in tesuturile endometrial si miometrial nivelul de ARN mesager pentru triptofanhidroxilaza-1,si in cazul, in care nivelul constituie 0…15 unitati se determina o agresivitate majora, 16…400 unitati – o agresivitate medie, 400 unitati si mai mult se determina o agresivitate scazuta a cancerului endometrial.
MDA20060139A 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial MD3244G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Publications (2)

Publication Number Publication Date
MD3244F1 true MD3244F1 (ro) 2007-02-28
MD3244G2 MD3244G2 (ro) 2007-12-31

Family

ID=37845198

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Country Status (1)

Country Link
MD (1) MD3244G2 (ro)

Also Published As

Publication number Publication date
MD3244G2 (ro) 2007-12-31

Similar Documents

Publication Publication Date Title
MA31435B1 (fr) Inhibition de metastases tumorales par des anticoprs anti-neuropiline 2
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
WO2010009342A3 (en) Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
EP1904290A4 (en) MICRO BEADS ON ALUMINUM PHOSPHATE BASE
MA30497B1 (fr) Anticorps et immunco-conjugues, et leurs utilisations.
EA200870029A1 (ru) Способ применения антагонистов il-6 с ингибиторами протеасом
UY27729A1 (es) Inhibidores de quinasas.
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
CY1113984T1 (el) Προϊοντα συζευξης μεϋτανσινοειδους dm1 με αντισωμα trastuzumab, συνδεδεμενα μεσω μη-διασπασιμου συνδετηρα και χρηση αυτων στη θεραπεια ογκων
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
EP2499486A4 (en) COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER
WO2005008248A3 (en) Diagnosis and treatment of cervical cancer
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
MA33323B1 (fr) Thérapie adjuvante de cancer
BRPI0707040B8 (pt) Método in vitro de seleção de um composto, método in vitro de previsão da presença de câncer, método de determinação in vitro da eficiência de um tratamento anticancerígeno e uso de um composto
CY1116133T1 (el) Κλασματα θρομβοσπονδινης (thrombospondin) και χρησεις αυτων σε κλινικες δοκιμες για καρκινο και δημιουργια αντισωματων και αλλων παραγοντων συνδεσης
EA200400029A1 (ru) КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА АЛЬДОСТЕРОНА И ИНГИБИТОРА ГМГ-КоА-РЕДУКТАЗЫ
EP2274437A4 (en) COMPOSITIONS AND METHODS FOR DETECTING EGFR MUTATIONS IN CANCER
FR3068045B1 (fr) Modeles de peau sensible reconstituee
WO2010028313A3 (en) Phosphoprotein analysis of carcinomas for assessment of drug sensitivity
WO2006116016A3 (en) Molecular determinants of egfr kinase inhibitor response in glioblastoma
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees